Abstract
Bystander activation, i.e., activation of T cells specific for an antigen X during an immune response against antigen Y may occur during viral infections. However, the low frequency of bystander-activated T cells has rendered it difficult to define the mechanisms and possible in vivo relevance of this nonspecific activation. This study uses transgenic mice expressing a major histocompatibility complex class I-restricted TCR specific for glycoprotein peptide 33-41 of lymphocytic choriomeningitis virus (LCMV) to overcome this limitation. CD8+ T cells from specific pathogen-free maintained, unimmunized "naive" TCR transgenic mice can differentiate into LCMV-specific cytolytic effector CTL during infections with vaccinia virus or Listeria monocytogenes in vivo or mixed lymphocyte culture in vitro. We show that in these model situations (a) nonspecifically activated CTL are able to confer antiviral protection in vivo, (b) bystander activation is largely independent of the expression of a second T cell receptor of different specificity, (c) bystander activation is not mediated by a broadly cross-reactive TCR, but rather by cytokines, (d) bystander activation can be mediated by cytokines such as IL-2, but not alpha/beta-IFN in vitro; (e) bystander activation is, overall, a rare event, occuring in vivo in roughly 1 in 200 of the LCMV-specific CTL during infection of TCR transgenic mice with vaccinia virus; (f) bystander activation does not have a significant functional impact on nontransgenic CTL memory under the conditions tested; and (g) even in the TCR transgenic situation, where unphysiologically high numbers of T cells of a single specificity are present, bystander activation is not sufficient to cause clinically manifest autoimmune disease in a transgenic mouse model of diabetes. We conclude that although bystander activation via cytokines may generate cytolytically active CTL from naive precursors, quantitative considerations suggest that this is usually not of major biological consequence.
MeSH Terms
Animals
Antigens, Viral
Autoantigens/immunology
Cell Differentiation
Coculture Techniques
Cross Reactions
Cytokines/immunology
Cytotoxicity, Immunologic
Diabetes Mellitus, Experimental/etiology,immunology
Glycoproteins/immunology
Immunologic Memory
Listeriosis/immunology
Lymphocyte Activation
Lymphocytic choriomeningitis virus/immunology
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Transgenic
Peptide Fragments/immunology
Receptors, Antigen, T-Cell/genetics,immunology
T-Lymphocytes, Cytotoxic/immunology
Vaccinia/immunology
Viral Proteins
Chemicals
Antigens, Viral
Autoantigens
Cytokines
Glycoproteins
Peptide Fragments
Receptors, Antigen, T-Cell
Viral Proteins
glycoprotein peptide 33-41, Lymphocytic choriomeningitis virus
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Ehl S
Institute of Experimental Immunology, Department of Pathology, University of Zurich, Switzerland.
Hombach J
Aichele P
Hengartner H
Zinkernagel R M
References (34)
34 references, click to expand
-
Expression of a second receptor rescues self-specific T cells from thymic deletion and allows activation of autoreactive effector function.
Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9102-7
PMID: 8799161
-
Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections.
J Exp Med. 1996 Jun 1;183(6):2489-99
PMID: 8676069
-
Memory T cell development in the absence of specific antigen priming.
J Immunol. 1996 Dec 15;157(12):5300-7
PMID: 8955176
-
Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinants.
J Exp Med. 1983 Dec 1;158(6):1804-21
PMID: 6196431
-
Induction of alloreactive cytotoxic T cells by acute virus infection of mice.
J Immunol. 1986 Feb 15;136(4):1186-93
PMID: 2418107
-
T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay?
J Exp Med. 1986 Oct 1;164(4):1075-92
PMID: 3489805
-
Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
Eur J Immunol. 1987 Jul;17(7):1007-13
PMID: 2440688
-
The immune response of the mouse to lymphocytic choriomeningitis virus. V. High numbers of cytolytic T lymphocytes are generated in the spleen during acute infection.
Eur J Immunol. 1987 Jul;17(7):937-42
PMID: 2886344
-
Molecular mimicry and autoimmune disease.
Cell. 1987 Sep 11;50(6):819-20
PMID: 3621346
-
Virus-induced polyclonal cytotoxic T lymphocyte stimulation.
J Immunol. 1989 Mar 1;142(5):1710-8
PMID: 2537363
-
Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen.
Nature. 1989 Nov 30;342(6249):559-61
PMID: 2573841
-
Is T-cell memory maintained by crossreactive stimulation?
Immunol Today. 1990 Jun;11(6):203-5
PMID: 2191683
-
Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.
Cell. 1991 Apr 19;65(2):305-17
PMID: 1901764
-
The synergy between naive and memory T cells during activation.
Immunol Today. 1991 Jun;12(6):184-8
PMID: 1878134
-
Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates.
J Virol Methods. 1991 Jun;33(1-2):191-8
PMID: 1939506
-
T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: implications for T cell allelic exclusion and antigen-specific repertoire.
J Exp Med. 1991 Dec 1;174(6):1371-83
PMID: 1836010
-
RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement.
Cell. 1992 Mar 6;68(5):855-67
PMID: 1547487
-
Exclusion and inclusion of alpha and beta T cell receptor alleles.
Cell. 1992 May 1;69(3):529-37
PMID: 1316241
-
Infection breaks T-cell tolerance.
Nature. 1992 Sep 3;359(6390):79-82
PMID: 1355854
-
Cytotoxic T lymphocytes show HLA-C-restricted recognition of EBV-bearing cells and allorecognition of HLA class I molecules presenting self-peptides.
J Immunol. 1992 Oct 1;149(7):2406-14
PMID: 1326579
-
High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
J Exp Med. 1993 Feb 1;177(2):317-27
PMID: 8093891
-
MHC molecules as peptide receptors.
Curr Opin Immunol. 1993 Feb;5(1):35-44
PMID: 7680871
-
Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha.
J Immunol. 1993 Jun 1;150(11):5185-94
PMID: 8496610
-
Expression of two T cell receptor alpha chains: dual receptor T cells.
Science. 1993 Oct 15;262(5132):422-4
PMID: 8211163
-
Expression of two alpha chains on the surface of T cells in T cell receptor transgenic mice.
J Exp Med. 1993 Nov 1;178(5):1807-11
PMID: 8228827
-
Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of autoimmunity.
Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):767-71
PMID: 7507253
-
Turnover of naive- and memory-phenotype T cells.
J Exp Med. 1994 Apr 1;179(4):1127-35
PMID: 8145034
-
Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.
J Exp Med. 1994 Jun 1;179(6):1933-43
PMID: 8195718
-
Functional role of type I and type II interferons in antiviral defense.
Science. 1994 Jun 24;264(5167):1918-21
PMID: 8009221
-
Antigen-independent activation of naive and memory resting T cells by a cytokine combination.
J Exp Med. 1994 Sep 1;180(3):1159-64
PMID: 8064232
-
Specificity and editing by apoptosis of virus-induced cytotoxic T lymphocytes.
Curr Opin Immunol. 1994 Aug;6(4):553-9
PMID: 7524536
-
Expression of two T cell receptor alpha chains on the surface of normal murine T cells.
Eur J Immunol. 1995 Jun;25(6):1617-23
PMID: 7614990
-
Induction of bystander T cell proliferation by viruses and type I interferon in vivo.
Science. 1996 Jun 28;272(5270):1947-50
PMID: 8658169
-
Immunopathology or organ-specific autoimmunity as a consequence of virus infection.
Immunol Rev. 1996 Aug;152:21-45
PMID: 8930666